Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial.

Hoffman, Jeremy John; Yadav, Reena; Das Sanyam, Sandip; Chaudhary, Pankaj; Roshan, Abhishek; Singh, Sanjay Kumar; Arunga, Simon; Matayan, Einoti; Macleod, David; Weiss, Helen Anne; +3 more... Leck, Astrid; Hu, Victor; Burton, Matthew J; (2020) Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial. BMJ open, 10 (9). e038066-. ISSN 2044-6055 DOI: https://doi.org/10.1136/bmjopen-2020-038066

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmjopen-2020-038066

Abstract

Share

Download

Filename: e038066.full-2.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar